What is the diagnosis and management plan for a 30-year-old female junior high school teacher with a 10-year history of recurrent, severe, throbbing headaches, nausea, and photophobia, now occurring almost daily with increased severity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Chronic Migraine with Medication-Overuse Headache

This patient has chronic migraine that has transformed from episodic migraine, complicated by medication-overuse headache from daily paracetamol use. 1, 2

Differential Diagnoses

Primary Diagnosis: Chronic Migraine with Medication-Overuse Headache

  • Chronic migraine criteria are met: ≥15 headache days/month for >2 months (she reports "almost 5x a week"), with original attacks fulfilling migraine without aura criteria (unilateral, throbbing, moderate-to-severe intensity, with nausea and photophobia, lasting 4-72 hours) 1, 2
  • Medication-overuse headache is present: Regular paracetamol use ≥15 days/month for >2 months (she takes it "almost 5x a week" for the past 2 months) 1, 2
  • The 10-year history of episodic migraine (3-4 times monthly) that recently transformed to near-daily headaches is the classic progression pattern 1

Other Differentials to Consider (but less likely):

  • Tension-type headache: Ruled out by unilateral, throbbing quality and associated nausea/photophobia 2
  • Secondary headache disorders: No red flags present (no fever, no focal neurological deficits, age <50, gradual onset, normal neurological exam) 2, 3
  • Giant cell arteritis: Age <50 years excludes this 2
  • Intracranial pathology: No progressive worsening over years, no awakening from sleep, no Valsalva aggravation 2, 3

Neuroimaging Decision

Neuroimaging is NOT indicated for this patient. 2, 3

Rationale Against Neuroimaging:

  • No red flags present: No recent head trauma, no new neurological symptoms/signs, age <50, no thunderclap onset, no fever/neck stiffness, no altered consciousness, normal neurological examination 2, 3, 4
  • Classic migraine pattern: 10-year history with typical migraine features that evolved to chronic migraine—this is an expected natural history 1
  • Normal neurological examination: Cranial nerves intact, normal motor/sensory/cerebellar function, no papilledema 2

When Neuroimaging WOULD Be Indicated:

  • New-onset headache after age 50 2, 3
  • Atypical aura or persistent neurological deficits 5, 2
  • Progressive worsening over weeks (not months/years) 3, 4
  • Headache awakening from sleep or brought on by Valsalva/cough 2, 3
  • Any abnormal neurological examination findings 2, 4

Management Plan

Step 1: Address Medication-Overuse Headache (CRITICAL FIRST STEP)

Immediate withdrawal of paracetamol is mandatory—this is the most important intervention. 1

  • Explain to the patient: Her daily paracetamol use is perpetuating and worsening her headaches 1
  • Abrupt discontinuation: Stop paracetamol completely (no tapering needed for non-opioid analgesics) 1
  • Warn about withdrawal period: Headaches may temporarily worsen for 2-10 days before improvement begins 1
  • Bridge therapy: Consider short course of prochlorperazine or metoclopramide for severe withdrawal symptoms 1, 6

Step 2: Initiate Prophylactic Therapy (START IMMEDIATELY)

Prophylactic treatment is mandatory for chronic migraine—this is not optional. 1, 2

First-Line Prophylactic Options:

  • Topiramate: The ONLY medication with proven efficacy in randomized controlled trials specifically for chronic migraine 1

    • Start 25 mg at bedtime, titrate by 25 mg weekly to target dose 100 mg daily (50 mg twice daily) 1
    • Warn about paresthesias, cognitive slowing, weight loss, kidney stones 1
  • Alternative first-line agents (evidence from episodic migraine, commonly used for chronic migraine):

    • Amitriptyline 10-75 mg at bedtime (useful if comorbid depression/insomnia) 1, 7
    • Propranolol 80-240 mg daily (avoid in smokers with potential reactive airway disease) 8, 7
    • Valproate 500-1000 mg daily (AVOID in women of childbearing age—see contraception discussion below) 1

Step 3: Optimize Acute Treatment (For Breakthrough Attacks)

Limit acute medication use to <10 days per month to prevent recurrence of medication-overuse headache. 1, 2

For Moderate-to-Severe Attacks:

  • Triptans are first-line: Sumatriptan 50-100 mg, rizatriptan 10 mg, or eletriptan 40 mg 1, 6
  • Combination therapy: NSAID (naproxen 500 mg) + triptan is more effective than either alone 6
  • Antiemetic: Metoclopramide 10 mg or prochlorperazine 10 mg for nausea 1, 6

For Mild-to-Moderate Attacks:

  • NSAIDs alone: Ibuprofen 400-800 mg, naproxen sodium 550 mg, or diclofenac potassium 50 mg 1, 6
  • Avoid paracetamol: Given her history of medication overuse 1

Critical Medication Rules:

  • Maximum 2 days per week for triptan use 1, 6
  • Maximum 10 days per month for any acute medication 1, 2
  • Implement headache diary: Track frequency to prevent medication overuse recurrence 1, 2

Step 4: Identify and Manage Triggers

  • Smoking cessation: She is a current smoker—this is a modifiable risk factor and contraindication to ergot derivatives 1, 7
  • Regular sleep schedule: Irregular sleep is a common trigger 1
  • Stress management: Teaching profession is high-stress; consider biofeedback or relaxation techniques 8, 7
  • Regular meals: Avoid fasting 1
  • Limit caffeine: Excessive caffeine can contribute to medication-overuse headache 1

Step 5: Follow-Up Schedule

  • 2 weeks: Assess medication withdrawal symptoms and tolerability of prophylactic medication 1
  • 4-8 weeks: Evaluate prophylactic efficacy (expect 50% reduction in headache days) 1
  • 3 months: If inadequate response, consider dose adjustment or alternative prophylactic agent 1
  • Neurology referral: If first-line prophylactic fails or diagnosis remains uncertain 2

Contraception Counseling

Combined hormonal contraceptives (pills, patches, rings) are CONTRAINDICATED in this patient. 1

Contraindication Rationale:

  • Migraine without aura + smoking: Combined hormonal contraceptives increase stroke risk in women with migraine, especially smokers 1
  • Age >35 + smoking: Additional cardiovascular risk factor 1
  • Even if she quits smoking, migraine without aura at age 30+ warrants caution with estrogen-containing contraceptives 1

Safe Contraceptive Options:

  • Progestin-only methods (SAFE and RECOMMENDED):

    • Progestin-only pills (desogestrel 75 mcg daily) 1
    • Depot medroxyprogesterone acetate injection (every 3 months) 1
    • Etonogestrel implant (3-year duration) 1
    • Levonorgestrel IUD (5-year duration) 1
  • Non-hormonal methods (SAFE):

    • Copper IUD (10-year duration) 1
    • Barrier methods (condoms, diaphragm) 1
    • Permanent sterilization (if family complete) 1

Critical Counseling Points:

  • Avoid valproate if pregnancy possible: Valproate is teratogenic and should NOT be used in women of childbearing potential unless highly effective contraception is ensured 1
  • If she chooses valproate for prophylaxis: Must use highly effective contraception (IUD or implant preferred) and sign informed consent regarding teratogenicity 1
  • Topiramate is safer: Also has some teratogenic risk but less severe than valproate; still requires contraception 1

Common Pitfall to Avoid:

  • Do NOT prescribe combined oral contraceptives to any woman with migraine who smokes or is >35 years old—this significantly increases stroke risk 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Approach to Assessment of Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Headache Disorders: Differentiating Primary and Secondary Etiologies.

Journal of integrative neuroscience, 2024

Guideline

Migraine Diagnosis and Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Migraine treatment.

Seminars in neurology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.